HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom's Macroglobulinemia

Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom's macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minim...

Descripción completa

Detalles Bibliográficos
Autor principal: Wallace, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125491/
https://www.ncbi.nlm.nih.gov/pubmed/32274227
http://dx.doi.org/10.1155/2020/6516037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125491/
https://www.ncbi.nlm.nih.gov/pubmed/32274227
http://dx.doi.org/10.1155/2020/6516037

Ejemplares similares